Immunological Adjuvants and Their Mode of Action
- 1 January 1992
- book chapter
- Published by Elsevier in Biotechnology (reading, Mass.)
- Vol. 20, 431-449
- https://doi.org/10.1016/b978-0-7506-9265-6.50025-7
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Immunological adjuvants: Desirable properties and side-effectsMolecular Immunology, 1991
- Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulationVaccine, 1990
- Microanatomy of Lymphoid Tissue During Humoral Immune Responses: Structure Function RelationshipsAnnual Review of Immunology, 1989
- Development of a New Therapeutic Approach to B Cell Malignancy. The Induction of Immunity by the Host Against Cell Surface Receptor on the TumorInternational Reviews of Immunology, 1989
- Structure and Function of Human and Murine Receptors for IgGAnnual Review of Immunology, 1988
- Characterization of a Nontoxic Monophosphoryl Lipid AClinical Infectious Diseases, 1987
- Necrotic inflammatory reaction induced by muramyl dipeptide in guinea pigs sensitized by tubercle bacilli.The Journal of Experimental Medicine, 1985
- Granuloma Formation in Normal Guinea Pigs Injected Interadermally With Aluminum and Zirconium CompoundsJournal of Investigative Dermatology, 1977
- THE ADJUVANT EFFECT OF MICROBIAL PRODUCTS ON THE IMMUNE RESPONSEAnnual Review of Microbiology, 1976
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974